Paid-members only Start-Upomics Illumina recently courted investors with a presentation on how their new product R&D pipeline is going to resurrect the Illumina stock price
Paid-members only Genomic Sequencing Oxford Nanopore says that the short-read vs long-read conversation is pointless because they can do both
Paid-members only Start-Upomics The 23andMe board tells Anne Wojcicki to do better in her attempt to take 23andMe private after a rocky 3 years as a public company
Paid-members only Protein Sequencing There are a lot of companies working on protein sequencing, so who is in the lead?
Paid-members only Omics One of the most underappreciated techniques in Omics is Hi-C. That needs to change
Paid-members only Start-Upomics Tempus' good very bad week included a $410m IPO, a lawsuit and a ~$20 swing in their post-IPO stock price
Paid-members only High-Throughput Sequencing If you thought the sequencing wars were hot already, have you considered what a $10 genome might do to them?
Paid-members only Start-Upomics Who's prioritizing bringing the next generation of sequencing technology to the clinic? The answer might surprise you.
Paid-members only High-Throughput Sequencing Another summer of sequencing is upon us. Whose sparkle will beguile the hearts of suitors and dazzle the eyes of onlookers?
Paid-members only Hype Cycles AlphaFold, the second coming of Christ or just another useful tool in the life sciences?
Paid-members only Genomic Sequencing Spatial omics (and other creative applications) might give that dying NovaSeq of yours a second life!
Paid-members only Genetics What happens if insurance companies start using your genetic data against you?
Paid-members only Genomics Featured Pacific Biosciences drops nearly 50% after a bad earnings report and a mind-boggling update to their product roadmap
Paid-members only Start-Upomics Featured Bionano Genomics recently announced it was laying off 1/3rd of its workforce
Paid-members only Start-Upomics Featured Reports of NanoString's death appear to have been severely overstated
Paid-members only Genomic Sequencing Featured Illumina ruffled some feathers this week with a video appeal to moderate sized "core labs"
Paid-members only Start-Upomics Featured Francis deSouza is back from his post-Illumina purgatory with a new AI start-up
Paid-members only Genomics Featured Complete Genomics wants America to give them a second chance. Should they?
Paid-members only Start-Upomics Featured Is the life sciences bankruptcy bloodbath waxing or waning? Let's hope Nanostring and Invitae aren't emblematic of what's to come!